cancer.immunodefence.com
Cancer: Brain Cancer Archives
http://cancer.immunodefence.com/brain-cancer
New Type of Cancer Drug Can Slow Deadliest Form of Brain Cancer, Pilot Study Shows. February 22, 2007 10:17 PM. DURHAM, N.C. - Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found. Continue reading New Type of Cancer Drug Can Slow Deadliest Form of Brain Cancer, Pilot Study Shows. February 19, 2007 1:45 PM. Avastin c...
cancer.immunodefence.com
Top 20 things that are more dangerous to children than lead paint in Mattel toys - Cancer
http://cancer.immunodefence.com/2007/09/top-20-things-that-are-more-da.html
Top 20 things that are more dangerous to children than lead paint in Mattel toys. September 6, 2007 10:24 AM. Published a very interesting article. Regarding different factors that are damaging our health. Parents directly poison their children every day with products far more dangerous than Mattel toys. Read the full article below. But heres the interesting part in all this: Parents directly poison their children every day with products far more dangerous than Mattel toys. Because theyre made in America.
allergy.immunodefence.com
Allergy: Insect Allergy Archives
http://allergy.immunodefence.com/insect-allergy
Schering-Plough to sell Danish anti-allergy drug. January 3, 2007 2:38 PM. COPENHAGEN (Reuters) - U.S. drug maker Schering-Plough Corp. SGP.N will develop and sell Denmarks ALK-Abello anti-allergy drug Grazax in North America, the Danish company said on Wednesday. Shares in the Danish company rose 7.1 percent to 1,550 crowns on the news. Continue reading Schering-Plough to sell Danish anti-allergy drug. Latex Allergy ». This page is a archive of recent entries in the Insect Allergy. Is the next category.
pharma.immunodefence.com
Analysis: Senate committee approves drug safety bill, but FDA still runs on Big Pharma money - Drugs & Medicaments
http://pharma.immunodefence.com/2007/04/analysis-senate-committee-appr.html
Analysis: Senate committee approves drug safety bill, but FDA still runs on Big Pharma money. April 24, 2007 3:08 PM. By Mike Adams, NewsTarget.com. The Bush Administration is against the bill and offered sharp objections to the bills provisions, saying it would slow down drug approvals. Republicans also argued that the banning of drug advertisements on television was unconstitutional. The bill aims to accomplish several things:. Analysis, commentary and satire by Mike Adams. Okay, lets get to the real s...
pharma.immunodefence.com
Drug maker Eli Lilly hit with foreign bribery charges - Drugs & Medicaments
http://pharma.immunodefence.com/2012/12/drug-maker-eli-lilly-hit-with-1.html
Drug maker Eli Lilly hit with foreign bribery charges. December 23, 2012 8:53 PM. Drug maker Eli Lilly has agreed to pay more than $29 million to settle charges that four of its international subsidiaries paid bribes to win business, the Securities and Exchange Commission announced Thursday. Related: Wal-Mart expands foreign corruption probe. Lilly units in Brazil and Poland were accused of paying smaller bribes, together totally around $109,000. In China, a Lilly subsidiary allegedly falsified expen...
pharma.immunodefence.com
Drugs & Medicaments: Birth Control Drugs Archives
http://pharma.immunodefence.com/birth-control-drugs
Eli Lilly and Company Responds to New York Times Article of 12/17/06. December 18, 2006 4:55 PM. INDIANAPOLIS, Dec. 16 /PRNewswire-FirstCall/ - Eli Lilly and Company , in a response to a story about Zyprexa in the December 17, 2006 edition of the New York Times. Adds important facts and perspectives that were not evident in the story. Continue reading Eli Lilly and Company Responds to New York Times Article of 12/17/06. Wrongful-Death Lawsuit Filed Against Ortho Evra Manufacturer Ortho-McNeil. Celena Dev...
pharma.immunodefence.com
U.K. drug giant buys vaccine firm - Drugs & Medicaments
http://pharma.immunodefence.com/2007/04/uk-drug-giant-buys-vaccine-fir.html
UK drug giant buys vaccine firm. April 24, 2007 3:24 PM. LONDON–AstraZeneca PLC said yesterday it is buying U.S.-based biotech drug maker MedImmune Inc. in a $15.6 billion (U.S.) deal that will allow the British company to enter the vaccines market. AstraZeneca, looking to strengthen its pipeline of future drugs as it faces patent challenges and escalating generic competition, will pay $58 per share for MedImmune, a 21 per cent premium to the stocks close Friday. This page contains a single entry by ID A...
pharma.immunodefence.com
GlaxoSmithKline reportedly threatened diabetes expert over Avandia warnings - Drugs & Medicaments
http://pharma.immunodefence.com/2007/11/glaxosmithkline-reportedly-thr.html
GlaxoSmithKline reportedly threatened diabetes expert over Avandia warnings. November 28, 2007 2:58 PM. NewsTarget) A diabetes expert has claimed that pharmaceutical company GlaxoSmithKline threatened him with legal action after he raised concerns about the safety of the companys anti-diabetes drug rosiglitazone, marketed as Avandia. GlaxoSmithKlines CEO J.P. Garnier has denied that the company made any threats, saying instead that Buse made a correction to his prior comments. November 28, 2007 2:58 PM.
pharma.immunodefence.com
Drugs & Medicaments: Biodefence Archives
http://pharma.immunodefence.com/biodefence
Xoma wraps up work on $15M biodefense contract. November 7, 2006 1:31 PM. Xoma Ltd. said Monday it completed its work under a $15 million government biodefense contract. The Berkeley company (NASDAQ: XOMA) said the National Institute of Allergy and Infectious Diseases (NIAID) gave its final acceptance of the contract, which it awarded to Xoma in March 2005. Xoma developed manufacturing processes for three anti-botulinum neurotoxin monoclonal antibodies. Xoma won a $16 million follow-on contract in July.
